Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021 - read this article along with other careers information, tips and advice on BioSpace
See more from David Lanfear, MD
Gene therapy for Danon Disease